Linked Life Data

20670818

Source:http://linkedlifedata.com/resource/pubmed/id/20670818

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-7-30
pubmed:abstractText
Conventional therapy for atopic dermatitis has evolved along with better understanding of underlying impaired barrier function, role of microorganisms, and immune abnormalities. Emollients, along with antimicrobial and topical anti-inflammatory therapies, remain the cornerstone of conventional therapy. Recent therapeutic advances include use of nonsteroidal therapy for epidermal barrier repair, along with proactive therapy with topical corticosteroids and calcineurin inhibitors. Minimal anti-inflammatory treatment of the underlying residual disease is the immunobiologic rationale for proactive therapy. Further progress in understanding this increasingly common disease will hopefully lead to more targeted therapies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1557-8607
pubmed:author
pubmed:copyrightInfo
Copyright 2010. Published by Elsevier Inc.
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
351-68
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Evolution of conventional therapy in atopic dermatitis.
pubmed:affiliation
Department of Dermatology and Allergy, Ludwig-Maximilian University, Frauenlobstrasse 9-11, D-80331 Munich, Germany. wollenberg@lrz.uni-muenchen.de
pubmed:publicationType
Journal Article, Review